Sue Popik, a pancreatic cancer survivor and member of PanCAN’s Volunteer Advisory Council (VAC), shares her thanks for PanCAN ...
With federal research budgets facing growing uncertainty, PanCAN remains committed to building a research ecosystem to ...
Pancreatic cancer survivor and PanCAN volunteer Tolair Jones shares her journey with three types of cancer and what motivated ...
Research Recovery Program is Designed to Sustain Laboratories and Preserve High-Quality, High-Potential NIH or DoD ...
Together, we can improve outcomes. PanCAN is honored that healthcare professionals from the following institutions have chosen us to help support their patients. Last year, these institutions: ...
Community for Progress is a key strategy of the Pancreatic Cancer Action Network’s comprehensive plan to fight the world’s toughest cancer. Through Community for Progress, PanCAN’s research grantees ...
The types of cancer people are getting and dying from most may be changing in the next 20 years, according to a new study. Published today in JAMA Network Open, PanCAN and our research partners at ...
FDA Approves New First-line Treatment Option for Metastatic Pancreatic Cancer: What You Need to Know
For the first time in more than a decade, the FDA has approved a new first-line treatment for patients with metastatic pancreatic cancer. After a clinical trial showed a positive survival benefit, the ...
Pancreatic cancer is anticipated to become the second leading cause of cancer-related death in the U.S. around 2020. More awareness of this disease must be gained to increase knowledge, action and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback